Published: 6 February 2020
Author(s): Luis Castilla-Guerra, Jose Antonio Perez de Leon, María del Carmen Fernandez-Moreno
Section: Letter to the Editor
Internists often treat patients with dyslipidemia or atherosclerotic cardiovascular disease (ASCVD); however, there remain questions regarding what degree of reduction in low density lipoprotein cholesterol (LDL-C) is sufficient, and what supporting evidence there is for this.